Stem cells in veterinary medicine--attempts at regenerating equine tendon after injury
- PMID: 17692415
- DOI: 10.1016/j.tibtech.2007.07.009
Stem cells in veterinary medicine--attempts at regenerating equine tendon after injury
Abstract
Stem cells have evoked considerable excitement in the animal-owning public because of the promise that stem cell technology could deliver tissue regeneration for injuries for which natural repair mechanisms do not deliver functional recovery and for which current therapeutic strategies have minimal effectiveness. This review focuses on the current use of stem cells within veterinary medicine, whose practitioners have used mesenchymal stem cells (MSCs), recovered from either bone marrow or adipose tissue, in clinical cases primarily to treat strain-induced tendon injury in the horse. The background on why this treatment has been advocated, the data supporting its use and the current encouraging outcome from clinical use in horses treated with bone-marrow-derived cells are presented together with the future challenges of stem-cell therapy for the veterinary community.
Similar articles
-
Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study.Equine Vet J. 2008 Mar;40(2):178-81. doi: 10.2746/042516408X276942. Equine Vet J. 2008. PMID: 18267891
-
Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon.Equine Vet J. 2010 Oct;42(7):636-42. doi: 10.1111/j.2042-3306.2010.00112.x. Equine Vet J. 2010. PMID: 20840579
-
The effect of intralesional injection of bone marrow derived mesenchymal stem cells and bone marrow supernatant on collagen fibril size in a surgical model of equine superficial digital flexor tendonitis.Equine Vet J. 2012 Sep;44(5):587-93. doi: 10.1111/j.2042-3306.2011.00514.x. Epub 2011 Dec 11. Equine Vet J. 2012. PMID: 22150794 Clinical Trial.
-
Growth and Development Symposium: Stem cell therapy in equine tendon injury.J Anim Sci. 2013 Jan;91(1):59-65. doi: 10.2527/jas.2012-5736. Epub 2012 Oct 16. J Anim Sci. 2013. PMID: 23100589 Review.
-
Functional tissue engineering for tendon repair: A multidisciplinary strategy using mesenchymal stem cells, bioscaffolds, and mechanical stimulation.J Orthop Res. 2008 Jan;26(1):1-9. doi: 10.1002/jor.20456. J Orthop Res. 2008. PMID: 17676628 Review.
Cited by
-
The Use of Adipose-Derived Progenitor Cells and Platelet-Rich Plasma Combination for the Treatment of Supraspinatus Tendinopathy in 55 Dogs: A Retrospective Study.Front Vet Sci. 2016 Sep 9;3:61. doi: 10.3389/fvets.2016.00061. eCollection 2016. Front Vet Sci. 2016. PMID: 27668218 Free PMC article.
-
Safety assessment of equine allogeneic tenogenic primed mesenchymal stem cells in horses with naturally occurring tendon and ligament injuries.Front Vet Sci. 2024 Feb 26;11:1282697. doi: 10.3389/fvets.2024.1282697. eCollection 2024. Front Vet Sci. 2024. PMID: 38468694 Free PMC article.
-
Biomimetic electrospun nanofibrous structures for tissue engineering.Mater Today (Kidlington). 2013 Jun 1;16(6):229-241. doi: 10.1016/j.mattod.2013.06.005. Mater Today (Kidlington). 2013. PMID: 25125992 Free PMC article.
-
Transcriptional Factors Related to Cellular Kinetics, Apoptosis, and Tumorigenicity in Equine Adipose-Derived Mesenchymal Stem Cells (ASCs) Are Influenced by the Age of the Donors.Animals (Basel). 2025 Jun 28;15(13):1910. doi: 10.3390/ani15131910. Animals (Basel). 2025. PMID: 40646808 Free PMC article.
-
The Lack of a Representative Tendinopathy Model Hampers Fundamental Mesenchymal Stem Cell Research.Front Cell Dev Biol. 2021 May 3;9:651164. doi: 10.3389/fcell.2021.651164. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34012963 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources